Thursday, November 21, 2024
type here...
- Advertisement -spot_img

TAG

Brokers

Business

Qualified brokers to provide clients UPI block or 3-in-1 trading account from February 1

whatnews.in -
SEBI has asked qualified stock brokers (QSBs) to provide their clients trading supported by blocked amount in the cash segment using the UPI...
Business

Broker’s call: Divi’s Lab (Sell)

whatnews.in -
Target: ₹3,890CMP: ₹5,893.80Divi’s Laboratories -Q2FY24 revenue came in better than our estimates but EBITDA margin was lower. As a result, revenue was 8...
Business

Broker’s call: Ashok Leyland (Buy)

whatnews.in -
Target: ₹290CMP: ₹224.25Surpassing our ₹920 crore estimate on the better-than-expected gross margin, Ashok Leyland’s Q2 EBITDA slipped 6 per cent y-o-y to ₹1,020 crore....
Business

NSEL Investors Forum proposes ₹1,950-crore settlement plan

whatnews.in -
Nearly 11 years after payment default on the National Spot Exchange Ltd (NSEL), the 63 moons technologies (erstwhile Financial Technologies)-promoted NSEL and brokers...
Business

Broker’s call: Aptus Value Housing Fin (Buy)

whatnews.in -
Target: ₹430CMP: ₹338.15Aptus Value Housing Finance reported earnings of ₹180 crore (in line with our estimates), up 23 per cent y-o-y and 6...
Business

Broker’s call: Saregama (Buy) – The Hindu BusinessLine

whatnews.in -
Target: ₹580CMP: ₹513.10Saregama India’s strong headline numbers masked the weakness in music licensing revenue. Consolidated revenue grew 40.3 per cent y-o-y, aided by...
Business

Broker’s call: Amara Raja E&M (Buy)

whatnews.in -
Target: ₹1,638CMP: ₹1,310.65In Q2-FY25, Amara Raja Energy & Mobility’s 4W OEM segment and telecom segment witnessed a decline in volumes, which impacted its...
Business

Broker’s call: Dr Reddy’s Lab (Hold)

whatnews.in -
Target: ₹1,449CMP: ₹1,303Dr Reddy’s quarterly earnings were above our expectations on the revenue front but lower on earnings. On the revenue front, DRRD...
Business

Broker’s call: Titan Co (Outperform)

whatnews.in -
Target: ₹3,880CMP: ₹3,177.50Titan Company’s Q2-FY25 y-o-y sales growth and commentary on Q3 growth were strong. However, jewellery margins were below our estimate, and...
Business

Broker’s call: Gland Pharma (Buy)

whatnews.in -
Target: ₹1,970CMP: ₹1,832.45Gland Pharma delivered better-than-expected operational performance for the quarter. Despite increased EBITDA loss at Cenexi y-o-y/q-o-q and a lower share of...
123...10Page 2 of 10

Latest news

- Advertisement -spot_img

© whatnews. All rights reserved.

About Us

WhatNews is your one-stop shop for financial news. From global markets to personal finance tips, we've got you covered.